Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial
Kallas, Esper Georges; Precioso, Alexander Roberto
; Palacios, Ricardo
; Thomé, Beatriz; Braga, Patrícia Emília
; Vanni, Tazio
; Campos, Lúcia M A; Ferrari, Lilian; Mondini, Gabriela
; Salomão, Maria da Graça
; Silva, Anderson da
; Espinola, Heloisa Maxímo
; Santos, Joane do Prado
; Santos, Cecilia L S; Timenetsky, Maria do Carmo S T; Miraglia, João Luiz
; Gallina, Neuza Maria Frazatti
; Weiskopf, Daniela; Sette , Alessandro; Goulart, Raphaella; Salles, Rafael Tavares; Maestri, Alvino; Sallum, Adriana Maluf Elias; Farhat, Sylvia Costa Lima; Sakita, Neusa Keico; Ferreira, Juliana C O A; Silveira, Cassia G T; Costa, Priscilla R; Raw, Isaias
; Whitehead, Stephen S; Durbin, Anna P.; Kalil, Jorge












metadata.dc.contributor
metadata.dc.contributor.external
metadata.dc.description.sponsorship
Document type
Article
Source
Kallas EG, Precioso AR, Palacios R, Thomé B, Braga PE, Vanni T, et al. Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial. Lancet Infect. Dis.. 2020 Mar;20(7):839-850. doi:10.1016/S1473-3099(20)30023-2.
Appears in Collections:
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.